Aberrant activation of the TNF-α system and production of fas and scavenger receptors on monocytes in patients with end-stage renal disease

Artificial Organs

Volumn 29, Issue 9, 2005, Pages 701-707

  Wu, Chia Chao ^a,b   Chen, Jin Shuen ^b   Lin, Shih Hua ^b   Chu, Pauling ^b   Lin, Yuh Feng ^b   Lin, Su Mei ^c   Liao, Tung Nan ^b,d  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^d CHUNG HWA UNIVERSITY OF MEDICAL TECHNOLOGY   (Taiwan)

Author keywords

Apoptosis; End stage renal disease; Fas; Scavenger receptor; Tumor necrosis factor alpha

Indexed keywords

BODY FLUIDS; CHEMICAL ACTIVATION; DIALYSIS; DISEASES; GLYCOPROTEINS; MACROPHAGES; TUMORS;

CHRONIC RENAL FAILURE; END-STAGE RENAL DISEASE; FAS; HAEMODIALYSIS; NORMAL CONTROLS; PERITONEAL DIALYSIS; SCAVENGER RECEPTOR; TNF Α; TUMOR NECROSIS FACTOR RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA;

CELL DEATH;

CD36 ANTIGEN; CD68 ANTIGEN; FAS ANTIGEN; SCAVENGER RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 2; UREMIC TOXIN;

ADULT; AGED; APOPTOSIS; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; LABORATORY TEST; LEUKOCYTE DIFFERENTIAL COUNT; LYMPHOCYTOPENIA; MALE; MONOCYTE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; UREMIA;

EID: 27744550473     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2005.29110.x     Document Type: Article

References (22)

1. Descamps-Latscha B, Jungers P. New molecular aspects of chronic uraemia and dialysis-related immunocompetent cell activation. Nephrol Dial Transplant 1996;11(Suppl. 2):121-4.
2. Goldblum SE, Reed WP. Host defenses and immunologic alterations associated with chronic hemodialysis. Ann Intern Med 1980;93:597-613.
3. Cohen G, Haag-Weber M, Horl WH. Immune dysfunction in uremia. Kidney Int Suppl 1997;62:S79-82.
4. Cohen JJ, Duke RC, Fadok VA, Sellins KS. Apoptosis and programmed cell death in immunity. Annu Rev Immunol 1992;10:267-93.
5. Krammer PH. CD95's deadly mission in the immune system. Nature 2000;407:789-95.
6. Savill JS, Wyllie AH, Henson JE, Walport MJ, Henson PM, Haslett C. Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest 1989;83:865-75.
7. Ren Y, Silverstein RL, Allen J, Savill J. CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis. J Exp Med 1995;181:1857-62.
8. Heidenreich S, Schmidt M, Bachmann J, Harrach B. Apoptosis of monocytes cultured from long-term hemodialysis patients. Kidney Int 1996;49:792-9.
9. Matsumoto Y, Shinzato T, Amano I, et al. Relationship between susceptibility to apoptosis and Fas expression in peripheral blood T cells from uremic patients: a possible mechanism for lymphopenia in chronic renal failure. Biochem Biophys Res Commun 1995;215:98-105.
10. Girndt M, Kohler H, Schiedhelm-Weick E, Schlaak JF, Meyer zum Buschenfelde KH, Fleischer B. Production of interleukin-6, tumor necrosis factor alpha and interleukin-10 in vitro correlates with the clinical immune defect in chronic hemodialysis patients. Kidney Int 1995;47:559-65.
11. Herbelin A, Nguyen AT, Zingraff J, Urena P, Descamps-Latscha B. Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor alpha. Kidney Int 1990;37:116-25.
12. Girndt M, Sester U, Kaul H, Kohler H. Production of proinflammatory and regulatory monokines in hemodialysis patients shown at a single-cell level. J Am Soc Nephrol 1998;9:1689-96.
13. van Riemsdijk-Van Overbeeke IC, Baan CC, Knoop CJ, Loonen EH, Zietse R, Weimar W. Quantitative flow cytometry shows activation of the TNF-alpha system but not of the IL-2 system at the single cell level in renal replacement therapy. Nephrol Dial Transplant 2001;16:1430-5.
14. Kreuzer KA, Rockstroh JK, Sauerbruch T, Spengler U. A comparative study of different enzyme immunosorbent assays for human tumor necrosis factor-alpha. J Immunol Methods 1996;195:49-54.
15. Mangan DF, Wahl SM. Differential regulation of human monocyte programmed cell death (apoptosis) by chemotactic factors and pro-inflammatory cytokines. J Immunol 1991;147: 3408-12.
16. Gotch FA, Sargent JA. A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 1985;28:526-34.
17. Moser B, Roth G, Brunner M, et al. Aberrant T cell activation and heightened apoptotic turnover in end-stage renal failure patients: a comparative evaluation between non-dialysis, haemodialysis, and peritoneal dialysis. Biochem Biophys Res Commun 2003;308:581-5.
18. Galli F, Ghibelli L, Buoncristiani U, et al. Mononuclear leukocyte apoptosis in haemodialysis patients: the role of cell thiols and vitamin E. Nephrol Dial Transplant 2003;18:1592-600.
19. Meier P, Dayer E, Blanc E, Wauters JP. Early T cell activation correlates with expression of apoptosis markers in patients with end-stage renal disease. J Am Soc Nephrol 2002;13:204-12.
20. Carracedo J, Ramirez R, Madueno JA, et al. Cell apoptosis and hemodialysis-induced inflammation. Kidney Int Suppl 2002:89-93.
21. Bird DA, Gillotte KL, Horkko S, et al. Receptors for oxidized low-density lipoprotein on elicited mouse peritoneal macrophages can recognize both the modified lipid moieties and the modified protein moieties: implications with respect to macrophage recognition of apoptotic cells. Proc Natl Acad Sci USA 1999;96:6347-52.
22. Ando M, Lundkvist I, Bergstrom J, Lindholm B. Enhanced scavenger receptor expression in monocyte-macrophages in dialysis patients. Kidney Int 1996;49:773-80.